Aspire Biopharma Files Amended 2025 Annual Report
Ticker: ASBP · Form: 10-K/A · Filed: 2026-04-08T17:26:34-04:00
Sentiment: neutral
Topics: amendment, annual-report, pharmaceuticals
TL;DR
Aspire Biopharma amended its 2025 10-K. Check financials.
AI Summary
Aspire Biopharma Holdings, Inc. filed an amended 10-K report on April 8, 2026, for the fiscal year ending December 31, 2025. The filing includes various exhibits such as financial statements and certifications. The company's principal business is in Pharmaceutical Preparations.
Why It Matters
This amended filing provides updated financial and operational details for Aspire Biopharma Holdings, Inc., crucial for investors and stakeholders to assess the company's performance and outlook.
Risk Assessment
Risk Level: low — This is a routine amended filing of an annual report, not indicating new or elevated risks.
Key Numbers
- 2265424 — iXBRL 10-K/A Size (Size of the main 10-K/A filing document in bytes.)
- 8568196 — Complete submission text file Size (Size of the complete submission text file in bytes.)
Key Players & Entities
- Aspire Biopharma Holdings, Inc. (company) — Filer of the 10-K/A
- 0001847345 (company) — CIK number for Aspire Biopharma Holdings, Inc.
- 2026-04-08 (date) — Filing date of the 10-K/A
- 2025-12-31 (date) — Period of report for the 10-K/A
- 2834 (company) — SIC code for Pharmaceutical Preparations
FAQ
What is the primary purpose of this 10-K/A filing?
This 10-K/A filing is an amendment to the annual report for Aspire Biopharma Holdings, Inc. for the period ending December 31, 2025.
When was this amended filing accepted by the SEC?
The amended 10-K/A filing was accepted by the SEC on April 8, 2026.
What is Aspire Biopharma Holdings, Inc.'s SIC code?
Aspire Biopharma Holdings, Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
What is the CIK number for Aspire Biopharma Holdings, Inc.?
The CIK number for Aspire Biopharma Holdings, Inc. is 0001847345.
Where is Aspire Biopharma Holdings, Inc. located?
Aspire Biopharma Holdings, Inc. has its mailing and business address at 23150 FASHION DRIVE, SUITE 232, ESTERO FL 33928.
From the Filing
EDGAR Filing Documents for 0001493152-26-015737 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] SEC Accession No. 0001493152-26-015737 Filing Date 2026-04-08 Accepted 2026-04-08 17:26:34 Documents 80 Period of Report 2025-12-31 Interactive Data Document Format Files Seq Description Document Type Size 1 10-K/A form10-ka.htm iXBRL 10-K/A 2265424 2 EX-23.1 ex23-1.htm EX-23.1 5251 3 EX-31.1 ex31-1.htm EX-31.1 18479 4 EX-31.2 ex31-2.htm EX-31.2 18555 5 EX-32.1 ex32-1.htm EX-32.1 9266 6 EX-32.2 ex32-2.htm EX-32.2 9074 7 GRAPHIC ex23-1_001.jpg GRAPHIC 19616 8 GRAPHIC aud_001.jpg GRAPHIC 4260 9 GRAPHIC aud_002.jpg GRAPHIC 7339 Complete submission text file 0001493152-26-015737.txt 8568196 Data Files Seq Description Document Type Size 10 XBRL SCHEMA FILE asbp-20251231.xsd EX-101.SCH 61628 11 XBRL CALCULATION FILE asbp-20251231_cal.xml EX-101.CAL 63094 12 XBRL DEFINITION FILE asbp-20251231_def.xml EX-101.DEF 298275 13 XBRL LABEL FILE asbp-20251231_lab.xml EX-101.LAB 514127 14 XBRL PRESENTATION FILE asbp-20251231_pre.xml EX-101.PRE 425700 83 EXTRACTED XBRL INSTANCE DOCUMENT form10-ka_htm.xml XML 966600 Mailing Address 23150 FASHION DRIVE, SUITE 232 ESTERO FL 33928 Business Address 23150 FASHION DRIVE, SUITE 232 ESTERO FL 33928 561-704-8527 Aspire Biopharma Holdings, Inc. (Filer) CIK : 0001847345 (see all company filings) EIN. : 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231 Type: 10-K/A | Act: 34 | File No.: 001-41293 | Film No.: 26849133 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)